$8.24
-0.23 (-2.72%)
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+506.1% upside
Low Target
$27.43
Average Target
$49.94
High Target
$65.11
Current Price
$8.24
Current
$8.24
$8.24
Target
$49.94
$49.94
$27.43
$49.94 avg
$65.11
Scenario Analysis
Bear Case
$27.43
232.9%
Low target
Base Case
$49.94
+506.1%
Avg target
Bull Case
$65.11
+690.2%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$11.90
-30.8% from high
52-Week Low
$6.47
+27.4% from low
Target vs 52W High
$49.94
+319.7% vs high
Next Earnings Report
Nov 16, 2026
2d
until earnings
EPS Est: $-0.83
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.4% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -18.5% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |